Mind the Medicine Gap
In this Open University programme on global access to medicines, Jon Pender of GlaxoSmithKline discusses the importance of intellectual property and why it is a critical mechanism to allow companies to generate funds for reinvestment to help create the medicines of the future.The programme also discusses how pharmaceutical companies can help to tackle neglected tropical diseases and improve access to medicines in developing nations.